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Resumo: 
Introdução: O vírus da hepatite E (HEV) pertence ao género Hepevirus da família 
Hepeviridae. O HEV é um vírus não envelopado, pequeno e com forma icosaédrica com 30-
32 nm de diâmetro e genoma (+) ssRNA. Existem 4 genótipos do vírus (1-4). Os genótipos 1 
e 2 estão associados a infecções exclusivamente humanas. Os genótipos 3 e 4 podem 
infectar suínos e outros mamíferos além dos humanos.  
O HEV é responsável por provocar geralmente uma hepatite aguda, sendo mais frequente 
em países em desenvolvimento. A principal via de transmissão do vírus é a via fecal-oral 
através da ingestão de águas ou alimentos contaminados. Nas regiões desenvolvidas os 
genótipos 3 e 4 podem ser responsáveis por focos de infecção devido ao potencial 
zoonótico. 
Objectivo: Avaliar a prevalência da infecção por HEV em javalis e veado de forma a testar a 
presença do vírus em águas residuais, de forma a avaliar o risco para a saúde pública causado 
pelo HEV, em Portugal. 
Métodos: Trinta amostras de fezes de javalis e veado, 28 amostras de bílis de javali e ainda 
30 amostras de águas residuais (15 amostras da entrada da ETAR (Estação de Tratamento de 
Águas Residuais) e 15 amostras da saída da ETAR), de vários locais do país, foram 
submetidas a extração do ácido nucleico seguida por amplificação RT-PCR em Tempo Real, 
para detectar a presença do genoma viral do HEV. 
Resultados: Não foi encontrado RNA do HEV em nenhuma amostra de fezes ou de bílis 
nos animais em estudo. 
Nas águas, 2 (13.3%) das 15 amostras colhidas à entrada das ETARs revelaram-se positivas 
para a presença do genoma do HEV, mas não foi encontrado genoma viral em nenhuma das 
amostras colhidas à saída da ETAR. 
Conclusões: Os resultados do presente estudo sugerem que o HEV ainda não se encontra 
disseminado pela população de javalis de Portugal. No entanto o HEV está presente no 
sistema de águas de Portugal e poderá causar epidemias através da ingestão de água 
contaminada com o vírus. Devemos estar alerta para as infecções causadas por HEV ainda 
que a maioria delas seja assintomática, uma vez que existe um risco maior para grávidas e 
doentes imunodeprimidos. Este risco é acrescido por não existir ainda um tratamento eficaz 
e sem contra-indicações para combater possíveis infecções sintomáticas ou ainda infecções 
crónicas, quer nos indivíduos saudáveis quer em imunodeprimidos. 
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Abstract: 
Introduction: Hepatitis E virus (HEV) belongs to the Hepevirus genus from the Hepeviridae 
family. HEV is a non-enveloped small icosahedral virus with 30-32 nm of diameter and a (+) 
ssRNA genome. There are four genotypes (1-4) of the virus, genotype 1 and 2 are 
associated with exclusive infection on humans, while genotype 3 and 4 can also infect pigs 
and other mammalians. HEV is responsible for a liver disease, generally an acute hepatitis, 
most frequent in developing countries, where the main way of transmission of HEV is fecal-
oral through the ingestion of contaminated water or food. In other regions genotypes 3 and 
4 may be causing outbreaks of infection through its zoonotic potential. 
Aim: Evaluate the prevalence of HEV infection in wild boars and deer as well as to its 
presence in wastewaters, in order to evaluate the risk for the public health caused by HEV, 
in Portugal. 
Methods: Thirty samples of wild boar and deer feces, 28 bile samples of wild boars and 30 
wastewaters samples (15 samples collected from the influent of the WWTP and 15 samples 
of the respective effluent of the WWTP) from across country, were submitted to nucleic-
acid extraction followed by RT-PCR Real Time amplifications aiming the detection of the 
viral genome of HEV.  
Results: No HEV-RNA was detected in all feces and bile samples from wild animals. 
Two (13.3%) out of the 15 influent WWTP samples revealed the presence of HEV-RNA, 
while the viral genome was not detected in any of the effluent samples. 
Conclusion: We find that HEV is not spread across the population of Portuguese wild 
boars. Nevertheless we acquired that HEV is in fact present in our country which can cause 
outbreaks by contaminated water ingestion. We must be alert to HEV infections, even if 
most of them are asymptomatic, there is a high risk for pregnant women and for 
immunosuppressed population, and until the moment no effective and risk free treatment is 
available either to a possible chronic infection or even to a clinical symptomatic infection for 
the general population. 
Keywords: Hepatitis E, wild boars, wastewaters, zoonotic infection, viral outbreaks
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1. Introduction 
 
1.1 Epidemiology 
HEV is responsible for a liver disease, usually an acute hepatitis, most frequent in developing 
countries. 
In these countries the main cases of hepatitis E result from outbreaks associated with 
ingestion of contaminated water. In developed countries the majority of hepatitis E infections 
are found to be sporadic and associated with traveling to endemic regions or small 
outbreaks due to ingestion of contaminated food. More recently some cases were found to 
be associated with zoonotic spread.  
1.2 Structure and genome 
HEV belongs to the Hepevirus genus from the Hepeviridae family. HEV is a small non-
enveloped icosahedral virus with 30-32 nm of diameter.(1-3) (2-11) This is a virus with positive 
single stranded RNA of 7.2kb with three open reading frames (ORF’s), who encode both 
structural and non-structural proteins. (Figure 1) The first open reading frame, located at the 
5'end, encodes the majority of enzymes that the virus needs for his replication, such as the 
RNA-dependent RNA-polymerase, the helicase, the protease and the methyltransferase, 
which are obtained after the post-translational cleavage that occurs to the polyprotein 
formed by transcription of ORF1.(1-3, 8-10, 12, 13) 
The ORF 2 encodes a structural protein responsible for the constitution of the viral capsid, 
and is located at the 3’ end of the genome. 
Finally the ORF 3 overlaps the other two ORF’s and encodes a phosphoprotein, which 
seems to be helpful in the virus replication and assembly plus cytoskeleton synthesis, but its 
function it’s not yet fully known. 
It is also known that the virus as a hipervariabe region on the ORF 1 that is responsible for 
the four known different genotypes.(2, 3, 9-12)  
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Figure  1 - HEV genome scheme(11) 
1.3 HEV genotypes and mode of transmission 
There are four genotypes of the hepatitis E virus (1-4). Genotypes 1 and 2 are exclusevely 
associated with infection on humans. Genotypes 3 and 4 are thought to infect pigs and other 
mammalians besides humans.(2, 11) Its these genotypes 3 and 4 that can lead us to suspect that 
the virus has a zoonotic potential.(4-7, 14-18) This suspicious results from several reports of 
sporadic cases of HEV infections on people living in countries without epidemiologic 
evidence of HEV infections and that hasn’t left their home country for a long period of time. 
The occurrence of these sporadic cases points to a possible different mode of transmission 
such as some kind of contact of those people with animals infected with HEV, for example.(6, 
16-23) These kind of situations have been associated with genotypes 3 and 4. It’s known that 
these specific genotypes infects wild boars and others wild animals as well as domestic pigs 
that are used for human consumption.(1, 14, 15, 17, 19) It's likely that the raw or undercooked 
meat can host the virus or even an occupational infection can occur.(7, 20, 23) If the meat isn't 
cooked properly and for the necessary time at a minimum temperature that destroy the 
virus it can be the vehicle for the infection, because being a naked virus as is known gives a 
greater resistance to these kind of virus and so they can still be viable even throw harsh 
conditions.(7, 15, 20, 23) An occupational infection may also occur in people that work at 
slaughterhouses due to the close contact with the animals.(20, 23, 24) The evaluation of the 
zoonotic nature of HEV infection is of extreme importance, as well as the estimation of the 
number of animals that it affects as well as the possibility of these animals to infect humans. 
By this manner it could be more efficient to prevent the population of being infected and 
create new groups of risk to this infection, such as hunters, pregnant women or even 
immunosuppressed people, for example.(2, 8, 14, 17, 18, 22, 23, 25)  
Another cause for these infections is the consumption of contaminated water, which can 
reach the natural courses of water and expose the population to the HEV.(7, 20, 23) 
Furthermore fruits or vegetables that may have been in contact with this water may also be 
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contaminated and possibly transmit the virus.(7, 23) So by this whole scheme we see that the 
infection with HEV may represent a serious problem of public health.(1, 8, 13, 17, 18, 21-23) 
Previous studies revealed that HEV can become a chronic infection in immunosuppressed 
patients, so it’s highly important to evaluate all the possible ways of its transmission specially 
to this specific population, which as we know is increasing in our country, much like in the 
rest of the world.(26) 
1.4 Clinical manifestations 
Normally the HEV infection is self-limited as an acute hepatitis with a period of incubation of 
40 days in average.(2, 3, 10, 12, 17, 27) It manifests as an icteric hepatitis normally allied with fever, 
abdominal pain, vomiting, dark urine, hepatomegaly and transaminases can also be high.(2, 3, 12, 
17, 27)  
Thirty to 50% of the infections are asymptomatic. The frequency and severity of clinical 
manifestations depend on the age of the affected individual, because different ages have 
different types of immune response and it's known that the consequences of the HEV 
infection depend highly on the immune system of the infected individual, so clinical 
manifestations are higher in early to mid-adulthood. HEV seems to have a special harshness 
in pregnant women with a higher risk of fulminant hepatitis in this population.(3, 27)  
1.5 Diagnostic 
The initial response by immune system to HEV infection is the production of specific IgM 
type antibodies at around 2 to 3 weeks after exposure to the virus.(17, 28) Meanwhile the ALT 
(aspartate aminotransferase) reaches its peak by the same time as the first antibodies appear 
and HEV-RNA can also be detected in stool and serum samples from this period until 2 to 3 
months after exposure, but its presence will disappear first in serum and later on stool 
samples too.(12, 28) Shortly after the IgM, the IgG specific antibodies will be produced against 
the virus and these type of antibodies will be maintained for a much longer period of time 
than the first ones. Nevertheless, it’s shown that these antibodies will also decrease through 
time as well, so we can assume that maybe they aren’t lifetime protectors against possible 
re-exposure to the virus in the future.(28) (Figure 2) 
The diagnostic of the infection is mostly based on serology with the search of anti-HEV IgM 
and anti-HEV IgG, and like other types of hepatitis a trace of the infection state can be made 
with these markers. 
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Figure 2- Clinical manifestations and markers of HEV infection(28) 
 
1.6 Treatment 
If HEV can become a chronic infection it is highly important that a treatment to this infection 
can be able to prevent or treat it.(2, 17, 22, 26)  
The treatment that has been tried and for now is showing some results is the same as used 
for treatment of HCV, by using the ribavirin and sometimes the association of it with the 
pegylated α-interferon.(2, 29) But this treatment has several problems and many side effects, 
such as influenza-like symptoms, neuropsychiatric effects and severe anemia. By this, it can’t 
be used to treat every type of infection, such as mild infections or more important the 
infection of pregnant women.(29) 
1.7 Prevention 
The prevention of infection by HEV passes through the ingestion of drinkable water mainly 
in endemic regions, implementation of correct habits of hygiene and the proper cooking of 
all meat and vegetables.(12)  
A vaccine exists but it’s not commercialized, and for now it’s only being used on Asia 
because of the higher prevalence of the infection in that region.  
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2. Objectives 
 
The aim of this study is to search for the prevalence of HEV infection in wild animals such as 
wild boars and test the presence of the virus himself in water used by humans in their 
normal daily routines and own consumption, in order to evaluate the risk for the public 
health caused by HEV. 
For that purpose, the presence of HEV genome was evaluated in stool and bile samples of 
wild boars and deer. To further explain and comprehend the levels of HEV circulating in the 
Portuguese community we also tested samples of wastewater treatment stations (WWTP) 
around the country, evaluating both influents and effluents of the station. By doing this study 
we can comprehend the spread of the virus in our country, both in wild animals and in the 
waters circulating and served to the population. Further, we can also ascertain if the 
treatment used in the water stations is suitable to fully destroy the virus in case it is present 
in the water that reaches the station. 
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3. Material and methods 
 
3.1 Samples 
 
3.1.1. Animal samples 
Stool and bile samples were obtained from a group of 29 wild boars and 1 deer, from the 
regions of Santarém and Portalegre. 
The samples were collected by a veterinarian in the proper amount needed and treated as 
dangerous because they could be contaminated with HEV and with minimal environmental 
contamination. Bile was extracted from the bile ducts and feces were removed directly from 
the bowls of the boars. Before extraction all samples were stored at -20ºC until processed, 
which keeps the viral RNA stable and with no risk of getting digested or fragmented from 
bacteria or environmental factors. 
A total of 30 stool samples and 28 bile samples were available for the study. 
3.1.2. Wastewater samples 
Wastewater samples from the influent and effluents of 15 WWTP of different regions of 
Portugal, were collected into sterile containers and stored at -20ºC until process. 
A total of 30 wastewater samples (15 from the influents and 15 from the effluents) was 
available for the study. 
3.2. Nucleic acid extraction 
 
In order to obtain the virus RNA the extraction kit QIAamp® Viral RNA Mini Kit (50) from 
QIAGEN, was used for all samples. Besides enabling the purification of RNA, this kit is also 
suitable to eliminate the major causes of interference in the PCR reaction.  
3.2.1. Extraction preparation 
Before start the nucleic acid extraction protocol, it is need to: 
 Balance the samples to room temperature 
 Make sure that buffers AW1 and AW2 were properly prepared 
 Prepare the mix AVL buffer/ Carrier RNA 
 Add 16,8µl of Carrier RNA previously reconstituted and preserved at -20ºC to 
1,68ml of AVL buffer (3 extractions) 
 This mix is stable for 48h at 2-8ºC 
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 If the AVL buffer presents some kind of precipitate it must be dissolved by warming 
up the buffer to 37ºC, and then let it cool to room temperature 
 Prepare a support with the following tubes: 
 2 x n eppendorf tubes of 2ml, for lysis phase 
 n extraction columns 
 4 x n collecting tubes of 2ml 
 n eppendorf tubes of 1,5ml, for the final elution of the viral RNA in which n is the 
number of samples processed 
 Correctly identify both tubes and columns matching them with the samples, putting 
also the date in the tube that will contain the eluate of viral RNA 
 For every round of extractions a negative control must be used, which should be 
made with sterile water instead of sample. 
3.2.2. Sample preparation 
3.2.2.1. Bile samples 
Bile samples were ready for nucleic acid extraction after being collected, so they could be 
used directly without any previous preparation procedure. 
3.2.2.2. Stool samples 
Two hundred miligrams of stool samples were suspended in 1.8ml of PBS. After mixing, a 
centrifugation was performed, for 15min at 3000g, and the supernatant was collected to an 
Eppendorf tube of 1.5ml, and stored at -20ºC until nucleic acid extraction. 
3.2.2.3. Wastewater samples 
Wastewater samples were submitted to a ultracentrifugation protocol as described below, in 
order to concentrate the present viral particles. 
1. Properly homogenize the water 
2. Pipette 25ml of water for each one of the 3 specific tubes of the ultracentrifuge 
3. Balance the tubes, with help from a balance 
4. Put the tubes on the rotor, close it, and put it in the ultracentrifuge 
5. Centrifuge for 90min at 41000 rpm and at room temperature 
6. In the end collect the supernatant and preserve it at -20ºC 
7. Release the pellets on 500µl of supernatant and transfer it to a glass tube, correctly 
sterilized  
8. Add about 500µl of chloroform 
9. Mix in the vortex  
Prevalence of HEV in Portugal - a study in wild animals and wastewaters 
 
9 
 
10. Centrifuge at 1500 rpm for 10 min 
11. Collect the liquid phase (superior one) to an Eppendorf tube of 1,5ml and conserve it 
at -20ºC until analysis  
3.2.3. Nucleic acid extraction protocol 
A volume of 140µl of sample prepared as described in previous sections were submited to 
the following nucleid acid extraction protocol. 
Protocol: 
1. Pipette 560µl of the mix AVL buffer/ carrier RNA for each Eppendorf tube of 2ml 
2. Add 140µl of the sample 
3. Mix on vortex for 15 seconds, immediately after addiction on each tube 
4. Incubate at room temperature (15-25ºC) for 10min 
5. Do a brief centrifugation of the tubes, to remove some drops that may be in the 
inside walls of the tubes or on the cap 
6. Add 560µl of ethanol (96-100%) 
7. Mix on vortex for 15 seconds, immediately after addiction on each tube 
8. Carefully apply 630µl of the previous mix into the column, properly labeled and with 
a collecting tube on it. It shouldn’t stay any air bubble between the filter of the 
column and the liquid. 
9. Centrifuge at 8000 rpm for 1 min at room temperature. If some part of the solution 
didn’t get filtered it must be centrifuged, at a higher speed, until all solution passes 
through the membrane 
10. Put the column on a new collecting tube and reject the previous one. Open the 
column gently. 
11. Carefully apply 630µl of the previous mix (from step 7) into the column, properly 
labeled and with a collecting tube on it. It shouldn’t stay any air bubble between the 
filter of the column and the liquid. 
12. Centrifuge at 8000 rpm for 1 min at room temperature. If some part of the solution 
didn’t get filtered it must be centrifuged, at a higher speed, until all solution passes 
through the membrane 
13. Put the column on a new collecting tube and reject the previous one. Open the 
column gently. 
14. Add 500µl of AW1 buffer. Close the column. 
15. Centrifuge at 8000 rpm for 1 min at room temperature 
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16. Put the column on a new collecting tube and reject the previous one. Open the 
column gently. 
17. Add 500µl of AW2 buffer. Close the column 
18. Centrifuge at max speed (14000 rpm) for 3 min at room temperature 
19. Put the column on a new collecting tube and reject the previous one. Open the 
column gently. 
20. Centrifuge at max speed for 1min 
21. Put the column on a new collecting tube and reject the previous one. Open the 
column gently. 
22. Add 60µl of AVE buffer, balanced at room temperature. Close the column 
23. Incubate at room temperature for 1min 
24. Centrifuge at 8000 rpm for 1 min at room temperature 
25. The solution in the bottom of the collecting tube contains the viral RNA (stable for 1 
year if kept between -20 and -80ºC). 
 
3.2.4. Controls 
Negative and positive controls were included in all experiment.  
HEV RNA was mixed with each of the different type of studied samples. In order to assure 
that the extraction procedure worked out as expected. 
Negative controls consisting of RNAse free water instead of normal sample, were also 
included in each experiment, in order to assure the absence of contamination problems. 
3.3. Viral RNA amplification and detection 
 
Extracted nucleic acid obtained from all the samples were submitted to a RT-qPCR in order 
to evaluate the presence of HEV genome. A set of 2 primers specific for the ORF2 region of 
HEV genome were used. (Table 1)(4) 
 
Table 1 - Set of primers used (4) 
  Position 
HEV Forward primer CCGACAGAATTRATTTCGTCGGC 6296 - 6318 
HEV Reverse primer ATACCCTTRTCYTGCTGIGCRTTCTC 6420 - 6395 
HEV-Probe FAM-CTCGCCATTGGCTGAGAC-MGB-NFQ 6367 - 6350 
 
Two amplification protocols were used. 
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3.3.1. Taqman® protocol 
This amplification protocol used a TaqMan chemistry for detection of the amplified product. 
For that purpose a TaqMan probe specific for the ORF2 region of HEV genome was used. 
(Table 1) 
Amplification reaction was carried out in a total volume of 25µl, containing the reagents 
described in Table 2. 
Table 2 - TaqMan protocol 
Superscript® III Platinum® One-Step qRT-PCR System kit 
300µM of each primer 
60µM of HEV probe 
12.5µl reaction mix * 
5µl of RNA 
RNAase Free water 
0.8µl of SuperscriptTM III RT/Platinum® Taq emzyme 
 
* the reaction mix already contains 0.4mM of each dNTP and 2.4mM of MgSO4. 
3.2.2. SYBR® Green protocol 
This amplification protocol used SYBR Green chemistry for detection of the amplified 
product. 
The amplification was carried out in a total volume of 25µl, containing the reagents indicated 
in Table 3: 
Table 3 - SYBR Green protocol 
iScriptTM One-Step RT-PCR Kit With SYBR® Green kit 
300µM of each primer 
12.5µl of 2x reaction buffer * 
5µl of RNA 
RNAase Free water 
 
* the reaction buffer already contains 0.4mM of each dNTP, iTaq DNA polymerase and 
20nM of SYBR Green. 
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3.3.3. Real-Time RT-PCR protocol 
 Amplification of nucleic acid and detection of amplified products were carried on BIORAD 
CFX-96 ® thermal cycler equipment. Real-Time RT-PCR reaction was performed under the 
conditions below (Table 4): 
Table 4 - Real-Time RT-PCR protocol 
 SYBR® Green TaqMan 
Hold-RT 50ºC 10min 50ºC 30min 
Denature 95ºC 5min 95ºC 2min 
Cycling (45cycles) 95ºC 10sec 95ºC 15sec 
60ºC 30sec 60ºC 60sec 
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4. Results 
4.1 Presence of HEV genome in biological samples from wild boars and 
deers 
Thirty stool samples and 28 bile samples collected from 29 wild boars and 1 deer were 
examined for the presence of HEV genome through 2 different amplification protocols. 
No HEV genome was detected in any of the evaluated stool samples. 
In respect to the bile samples, 23 out of the 28 studied samples rendered an undetectable 
result, and the other 5 samples revealed a suspicious result by the SYBR Green protocol. 
Nevertheless, the analysis of these 5 samples through the TaqMan protocol confirmed the 
inexistence of detectable HEV-RNA. 
 
4.2 Prevalence of HEV genome in wastewaters from Portugal 
Thirty wastewater samples from different regions of Portugal were evaluated for the 
presence of HEV genome through the TaqMan amplification protocol described above. 
The obtained results are shown in Table 5. 
Table 5 - Results from wastewaters 
Sample type Number of samples 
Tested With HEV genome (%) 
Influent (WWTP) 15 2 (13.3%) 
Effluent (WWTP) 15 0 (0%) 
Total 30 2 (6.67%) 
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5. Discussion and Conclusions 
 
We evaluate Portuguese wild animals and wastewaters for the presence of HEV, in order to 
clarify the possible danger to the public health caused by the hepatitis E virus. 
From the results obtained with the two amplification protocols, it was evident that the use 
of Real Time RT-PCR TaqMan protocol is preferable to the SYBR Green protocol, once 
nonspecific amplification was observed with the last one in some samples. The evaluations of 
these samples through the TaqMan protocol render undetectable results. These results may 
be associated with the low number of RNA copies in samples or it can also be due to 
unspecific amplification with SYBR Green, as this protocol doesn't have a specific probe to 
the genome and binds to all double stranded chains that may appear in the amplification 
reaction. 
All wild boars and deer samples were found negative to HEV genome, so we may be leading 
to think that HEV is not present in great quantity in the wild animals of our country. In a 
similar Spanish study, HEV-RNA was found in 37.7% of the animals tested, being detected in 
19.1% of the bile samples and in 12.3% of feces samples. (14) Another similar study in Portugal 
showed a prevalence of HEV up to 30% in domestic pigs. (5) There are also published data 
about HEV autochthonous infections, in Portugal and India, showing that the virus has indeed 
a zoonotic potential and the source of the infections must be the environment or animals 
like wild boars or domestic pigs. (4, 6) The fact we didn't find any positive sample could be 
related with the use of different primers and different conditions of amplification and 
extraction. We have also to consider the fact that we used a smaller number of samples (the 
previous study was performed on 69 animals).  
Seroepidemiological studies demonstrated the presence of HEV specific antibodies in 51% of 
specific populations, like swine farmers, while the seroprevalence for the general population 
was of 25% only. (1, 15) Another study, revealed a seroprevalence of 31% in forest workers.(24) 
It is highly important to understand if these populations are at high risk of infection due to its 
higher level of exposure to HEV, through the contact with infected animals.  
It would be important to fully understand the spread of HEV in Portugal. For the healthy 
population, from around the different continents, a major study was made to evaluate the 
prevalence of antibodies against HEV, and the data found showed a lower prevalence of 
antibodies on the samples tested in comparison to the high exposure population samples, 
like farmers and forest workers.(25) But when the study was performed in a greater number 
of samples, the percentage of antibodies found also raised proportionally, to levels of 77% in 
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the Asia region and 27% in Europe. (25) A study with blood donors on Europe showed a sero 
prevalence of 6.8%. (13) Since the majority of these studies were made in developed countries 
we can discard the main transmission way of HEV. By this we have to think that the 
percentages found in the different studies can't be all due to exclusively human HEV 
genotypes (1-2), but more likely the transmission and contact with HEV should be the 
zoonotic way with genotypes 3 and 4.  
During our study, two water samples were found positive, which lead us to think that the 
contamination of those waters may be due to feces from infected animals or even humans. 
Anyway, it would be important to know the origin of this contamination. An hypothesis 
chance is that the contamination of waters comes from domestic pigs raised in farms or for 
personal consumption, once they are related to wild boars and as published before, pigs 
represent one of the most frequently infected animals by HEV.  
To get the idea of the reason those waters were contaminated we need to study animal 
populations from the regions were the samples of wastewaters were found positive and 
further analyze the nucleotide sequence of HEV-RNA found on pigs as well as those found in 
the water samples. If the genotype is the same we can assume that the soil contamination 
from pigs feces leads to consequent water contamination. If none or very few of the pigs is 
found infected we need to found if the contamination of waters is made by human 
contamination.  
Furthermore, it would also be interesting to evaluate the HEV infection in Portuguese 
individuals through a seroprevalence study, doing the screening of specific groups of 
population for either IgG or IgM against HEV, such as hunters, farmers, pregnant women and 
immunosuppressed patients since these are the high risk groups because of the exposure in 
one case and for the consequences of the infection in the other. 
Another problem raised from our study is the fact that if water samples were found positive 
we know that HEV is circulating in the environment. Both positive influent samples for HEV-
RNA were found negative on the effluent samples, so we could say that the treatment 
process is working in the right way for the elimination of the virus from water used by 
humans.  
In conclusion we acquired that HEV is present in our country with the risk to cause 
outbreaks by contaminated water ingestion and since we can’t discard the HEV infection just 
due to the majority of the cases be asymptomatic, there is a high potential for HEV to 
become a serious public health problem. 
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